Get the Weekly Intelligence Brief — top committee picks every Sunday.
MPT · NYSE · STOCK

Medical Properties Trust (MPT) Stock Analysis

Real Estate Updated October 10, 2026
$3.13
52W $3.08 – $6.47
44/100
$1.88B
-59.8
1.49
AI Committee Verdict
Watch
44/100
Conviction: Contested · 50% agreement · 6 analysts
+47.9%
Contested

Is MPT Bullish or Bearish?

Mixed. Innellis AI committee rates Medical Properties Trust, Inc. (MPT) Watch with a composite score of 44/100 , based on 6 analysts with 50% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +15.71 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -4.29 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • ROE of only -0.7% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 2.11 adds balance-sheet risk to the value case — Value
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • Price structure making lower highs and lower lows — Technical
  • RSI at 20 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
44/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 97%
of 80 Real Estate peers
Value Analyst bearish
32 / 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− ROE of only -0.7% -- cheap may mean cheap for a reason
Growth Analyst neutral
50 / 100 · Moderate confidence
Moderate growth -- present but not remarkable
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
41 / 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement
− Price structure making lower highs and lower lows
Risk Analyst bearish
32 / 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 2.11) amplifies downside in a stress scenario
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
44 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
− News sentiment is negative (-0.40 across 5 articles, 14d)
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 44.7 to 44.3.

Analyst-level changes:
  • News Analyst: +1 bearish signal(s).
  • Risk Analyst: +1 bearish signal(s).
  • Technical Analyst: +2 bearish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
20.4
Oversold
MACD Histogram
-0.011
Bearish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Mixed
Bollinger %B
0.02
Inside Bands
Price vs Moving Averages
EMA 9
$3.29 Below
EMA 21
$3.47 Below
EMA 50
$3.81 Below
EMA 200
$4.50 Below

Fundamental Analysis

Valuation
100
Growth
15
Profitability
25
Financial Health
9
Cash Flow
70
Valuation
P/E Ratio -59.8×
P/B Ratio 0.42×
PEG Ratio -0.11
Dividend Yield 11.46%
52W High $6.47
52W Low $3.08
Quality & Growth
ROE -601.3%
ROA -184.7%
Gross Margin 8248.0%
Operating Margin 5661.0%
Revenue Growth YoY —
Debt / Equity 2.16
AI Fundamental Assessment
P/E ratio of -59.8 (inexpensive relative to a 15-40x range); Price-to-book of 0.4x; PEG ratio of -0.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -6.0%; Return on assets of -1.8%; Net margin of -3.0%; Gross margin of 82.5%; Current ratio of 0.31 (tight short-term liquidity); Debt-to-equity of 2.16; Free cash flow per share is positive (0.38); Most recent quarter missed estimates by 231.6%; EPS growth decelerating (+66.7% -> -120.0% QoQ); Analyst estimates falling over recent quarters
Get the Full MPT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime